EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ

Odette Solís, Jamin Addae, Raeshell Sweeting, Ingrid Meszoely, Ana Grau, Rondi Kauffmann, Mark Kelley, Rachel McCaffrey, Kelly Hewitt

Breast Cancer Research and Treatment · 2024-12 · 208 (3) · 565-568

DOI: 10.1007/s10549-024-07451-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 01.08.2024. Verfasst von Odette Solís und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology & Endocrine Surgery, Vanderbilt University Medical Center, Preston Research Building, 597, 2220 Pierce Avenue, Nashvill…. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sentinel Lymph Node Biopsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Recent studies have established the safety and efficacy of Superparamagnetic Iron Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with ductal carcinoma in situ (DCIS) who are undergoing mastectomy. The aim of our study was to measure cost containment with use of Magtrace® in comparison to upfront SLNB with traditional technetium-99 lymphatic tracer.

Methods

A total of 41 patients at our institution underwent mastectomy with Magtrace® injection for DCIS and were included in our single-institution, retrospective analysis. For comparison, total charges data were obtained for an upfront SLNB at the time of mastectomy. Cost comparison analysis was then performed against charges for intraoperative Magtrace® injection with additional charges incorporated for those patients who required return to the operating room for delayed SLNB. Total cost containment for the cohort with use of Magtrace® was then measured.

Results

Of the 41 patients who underwent Magtrace® injection, two patients required return to the operating room for a delayed SLNB for invasive disease. Including these charges for a second encounter into our cost analysis, the use of Magtrace® still yielded an overall cost containment of $205,793.55 in our cohort when comparing to patients who underwent upfront SLNB. For patients who underwent Magtrace® injection and did not require return to the operating room, charges were reduced by $6,768.52 per patient.

Conclusion

The use of Magtrace® for delayed SLNB in patients with DCIS undergoing mastectomy yielded a significant overall cost containment, further supporting its use in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingSentinel Lymph Node BiopsyHumansFemaleMiddle AgedAgedRetrospective StudiesAdultMastectomyMagnetic Iron Oxide NanoparticlesMagnetite Nanoparticles

Stichwörter der Autor:innen

Cost analysisDuctal carcinoma in situMastectomySPIO

Substanzen

Magnetite Nanoparticles

Autor:innen und Institutionen

  • Division of Surgical Oncology & Endocrine Surgery, Vanderbilt University Medical Center, Preston Research Building, 597, 2220 Pierce Avenue, Nashville, TN, 37232, USA. odettekassarsolis@gmail.com.
  • Division of Surgical Oncology & Endocrine Surgery, Vanderbilt University Medical Center, Preston Research Building, 597, 2220 Pierce Avenue, Nashville, TN, 37232, USA.

Zitieren

APA

Solís, O., Addae, J., Sweeting, R., Meszoely, I., Grau, A., Kauffmann, R., Kelley, M., McCaffrey, R., & Hewitt, K. (2024). Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ. Breast Cancer Research and Treatment, 208(3), 565-568. https://doi.org/10.1007/s10549-024-07451-2

Vancouver

Solís O, Addae J, Sweeting R, Meszoely I, Grau A, Kauffmann R, et al. Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ. Breast Cancer Research and Treatment. 2024;208(3):565-568. doi:10.1007/s10549-024-07451-2

BibTeX
@article{Sols2024,
  author = {Solís, Odette and Addae, Jamin and Sweeting, Raeshell and Meszoely, Ingrid and Grau, Ana and Kauffmann, Rondi and Kelley, Mark and McCaffrey, Rachel and Hewitt, Kelly},
  title = {Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  volume = {208},
  number = {3},
  pages = {565--568},
  doi = {10.1007/s10549-024-07451-2}
}
Kostenlos starten →